{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:27:27Z","timestamp":1790692047684,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jad.2020.09.124","type":"journal-article","created":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T22:27:41Z","timestamp":1601936861000},"page":"158-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Acute Effects of Cannabis on Symptoms of Obsessive-Compulsive Disorder"],"prefix":"10.1016","volume":"279","author":[{"given":"Dakota","family":"Mauzay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"LaFrance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Cuttler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2020.09.124_bib0001","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/02791072.2012.736808","article-title":"Mental health symptoms and their relationship to cannabis use in adolescents attending residential treatment","volume":"44","author":"Albertella","year":"2012","journal-title":"J Psychoact Drugs"},{"key":"10.1016\/j.jad.2020.09.124_bib0002","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"10.1016\/j.jad.2020.09.124_bib0003","series-title":"Diagnostic and statistical manual of mental disorders","year":"2000"},{"key":"10.1016\/j.jad.2020.09.124_bib38","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2020.09.124_bib0005","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.addbeh.2007.04.004","article-title":"Marijuana use motives and social anxiety among marijuana using young adults","volume":"32","author":"Buckner","year":"2007","journal-title":"Addict Behav"},{"key":"10.1016\/j.jad.2020.09.124_bib0006","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/FBP.0b013e32833b33c5","article-title":"Cannabidiol inhibitory effect on marble-burying behavior: Involvement of CB1 receptors","volume":"21","author":"Casarotto","year":"2010","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.jad.2020.09.124_bib0007","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1176\/appi.neuropsych.16030053","article-title":"Refractory OCD due to thalamic infarct with response to dronabinol","volume":"29","author":"Cooper","year":"2016","journal-title":"Journal Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jad.2020.09.124_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2019.11.001","article-title":"Short- and long-term effects of cannabis on headache and migraine","author":"Cuttler","year":"2020","journal-title":"J Pain."},{"key":"10.1016\/j.jad.2020.09.124_bib0009","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jad.2018.04.054","article-title":"A naturalistic examination of the perceived effects of cannabis on negative affect","volume":"235","author":"Cuttler","year":"2018","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jad.2020.09.124_bib0010","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00213-003-1719-0","article-title":"Self-reported psychopathological symptoms. In recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: Further evidence from a combined cross-sectional\/longitudinal investigation","volume":"173","author":"Daumann","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2020.09.124_bib0011","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00213-011-2415-0","volume":"3","author":"Deiana","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2020.09.124_bib0012","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1097\/00004583-199511000-00008","article-title":"Obsessive-compulsive disorder in a birth cohort of 18-year-olds: Prevalence and predictors","volume":"34","author":"Douglass","year":"1995","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.jad.2020.09.124_bib0013","unstructured":"Drug Enforcement Administration. Title 21 United States Code (USC) Controlled Substances Act - Section 812 - Schedules of Controlled Substances, 2018. Retrieved from https:\/\/www.deadiversion.usdoj.gov\/21cfr\/21usc\/812.htm."},{"key":"10.1016\/j.jad.2020.09.124_bib37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.5271\/sjweh.752","article-title":"Validity of a single-item measure of stress symptoms","volume":"29","author":"Elo","year":"2003","journal-title":"Scand. J. Work Environ. Health"},{"key":"10.1016\/j.jad.2020.09.124_bib0014","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1037\/0022-006X.68.4.594","article-title":"Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: Randomized compared with nonrandomized samples","volume":"68","author":"Franklin","year":"2000","journal-title":"J. Consult Clin Psychol."},{"key":"10.1016\/j.jad.2020.09.124_bib0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jad.2020.09.124_bib0016","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0272-7358(96)00043-8","article-title":"Nonclinical populations in research on obsessive-compulsive disorder","volume":"16","author":"Gibbs","year":"1996","journal-title":"A critical review. Clin Psychol Rev."},{"key":"10.1016\/j.jad.2020.09.124_bib0017","doi-asserted-by":"crossref","first-page":"640","DOI":"10.4088\/JCP.v64n0604","article-title":"A double-blind placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder","volume":"64","author":"Hollander","year":"2003","journal-title":"J Clin Psychiat"},{"key":"10.1016\/j.jad.2020.09.124_bib0018","first-page":"1","article-title":"Acute effects of cannabinoids on symptoms of obsess0ive compulsive disorder: A human laboratory study","author":"Kayser","year":"2020","journal-title":"Depress Anxiety."},{"key":"10.1016\/j.jad.2020.09.124_bib0019","doi-asserted-by":"crossref","DOI":"10.1097\/JCP.0000000000001179","article-title":"Cannabis augmentation of exposure-based psychotherapy for obsessive-compulsive. disorder","author":"Kayser","year":"2020","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jad.2020.09.124_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/can.2018.0049","article-title":"The endocannabinoid system: A new treatment for obsessive compulsive disorder?","volume":"4","author":"Kayser","year":"2019","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jad.2020.09.124_bib0021","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02244217","article-title":"Salivary THC following cannabis. Smoking correlates with subjective intoxication and heart rate","volume":"103","author":"Menkes","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2020.09.124_bib0022","series-title":"Mplus user's guide","author":"Muth\u00e9n","year":"2017"},{"key":"10.1016\/j.jad.2020.09.124_bib0023","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/da.20387","article-title":"The latent structure of obsessive-compulsive symptoms: A taxometric study","volume":"25","author":"Olatunji","year":"2008","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jad.2020.09.124_bib0024","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/fcp.12051","article-title":"Cannabidiol reverses the mCPP-induced increase in marble-burying behavior","volume":"28","author":"Nardo","year":"2014","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.jad.2020.09.124_bib0025","series-title":"The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research","year":"2017"},{"key":"10.1016\/j.jad.2020.09.124_bib0026","unstructured":"National Institute on Drug Abuse, 2016. Marijuana plant material available from the NIDA drug supply program. Retrieved from https:\/\/www.drugabuse.gov\/research\/research-data-measures-resources\/nida-drug-supply-program\/marijuana-plant-material-available-nida-drug-supply-program."},{"key":"10.1016\/j.jad.2020.09.124_bib0027","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.janxdis.2016.03.006","article-title":"Dropout rates in exposure with response prevention for obsessive-compulsive disorder: What do the data really say?","volume":"40","author":"Ong","year":"2016","journal-title":"J Anxiety Disord."},{"key":"10.1016\/j.jad.2020.09.124_bib0028","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.psc.2014.05.006","article-title":"Pharmacological al treatment of obsessive-compulsive disorder","volume":"37","author":"Pittenger","year":"2015","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.jad.2020.09.124_bib0029","series-title":"Neuroscientific basis and practical applications","article-title":"Stahl's essential psychopharmacology","author":"Stahl","year":"2013"},{"key":"10.1016\/j.jad.2020.09.124_bib0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/can.2016.0007","article-title":"A cross-sectional survey of cannabis medical users: Patterns of use and perceived efficacy","volume":"1","author":"Sexton","year":"2016","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jad.2020.09.124_bib0031","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/add.13886","article-title":"Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state","volume":"112","author":"Smart","year":"2017","journal-title":"Addiction"},{"key":"10.1016\/j.jad.2020.09.124_bib0032","unstructured":"Society of Clinical Psychology, 2015. Treatment target: Obsessive-compulsive disorder. Retrieved from https:\/\/www.div12.org\/diagnosis\/obsessive-compulsive-disorder\/."},{"key":"10.1016\/j.jad.2020.09.124_bib0033","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.addbeh.2017.03.023","article-title":"Symptoms of obsessive-compulsive disorder predict cannabis misuse","volume":"72","author":"Spradlin","year":"2017","journal-title":"Addict Behav"},{"key":"10.1016\/j.jad.2020.09.124_bib0034","first-page":"52","article-title":"Case report of comorbid schizophrenia and obsessive compulsive disorder in a patient who was tube-fed for four years by his family members","volume":"27","author":"Sachdeva","year":"2015","journal-title":"Because of his refusal to eat. Shanghai Archiv Psychiatry."},{"key":"10.1016\/j.jad.2020.09.124_bib0035","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1176\/appi.ajp.2007.07061016","article-title":"Improvement in refractory obsessive-compulsive disorder with dronabinol","volume":"165","author":"Schindler","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jad.2020.09.124_bib0036","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1177\/026988119300700112","article-title":"Effects of ipsapirone and cannabidiol on human experimental anxiety","volume":"7","author":"Zuardi","year":"1993","journal-title":"J. Psychopharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720328202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032720328202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:51:05Z","timestamp":1759024265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032720328202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":37,"alternative-id":["S0165032720328202"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2020.09.124","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Effects of Cannabis on Symptoms of Obsessive-Compulsive Disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2020.09.124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}